AzTrials
AzTrials

Anesthesia Intubation ComplicationGlidescopeNCT01424605

The Comparison of Glidescope® and the Direct Laryngoscopy in the Insertion of the Double Lumen Endotracheal Tube

A study testing DLT intubation in people with Anesthesia Intubation Complication, run by Kaohsiung Medical University Chung-Ho Memorial Hospital at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Double-lumen bronchial tube (DLT) had been demonstrated to benefit for thoracic surgery and also played an important role to achieve one-lung ventilation (OLV) for exploring the surgical fields. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Anesthesia Intubation Complication
What is being tested?
DLT intubation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTaiwan
Study dates
Jan 2010to Dec 2010
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Anesthesiologists physical status I-III, ≧ 18 years of age, and needed double-lumen endotracheal tube (DLT) for thoracic surgery

Who cannot join

  • increased risk for regurgitation and pulmonary aspiration, history of gastroesophageal reflux, and pregnancy
  • a tracheostomy or prolonged ventilation on ICU was planned, patients were also excluded

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • department of anesthesia, Kaohsiung medical university memorial hospital

    Kaohsiung, Taiwan, 807

Other trials in Taiwan

About this study

Double-lumen bronchial tube (DLT) had been demonstrated to benefit for thoracic surgery and also played an important role to achieve one-lung ventilation (OLV) for exploring the surgical fields. However, compared with the single-lumen endotracheal tube (SLT), the DLT had larger OD (outer diameter), longer length, and was more complex in its structure. For avoiding oral tissue trauma and shortening the DLT intubating time, thus, an adequate and complete glottic viewing under laryngoscope was needed.

Over the past decade, several video-assisted laryngoscopes had been developed to facilitate the tracheal intubation in the difficult airway. Among these devices, the GlideScope® videolaryngoscope (GVL) (Verathon, Bothell, WA, USA) was a reusable video laryngoscope with a 60° curvature blade. A light source and a digital video camera were installed at the tip of the laryngoscope blade and the pictures of the glottis and the vocal cords were displayed on an LCD monitor. We could insert the endotracheal tube passing the vocal cords into the trachea more precisely and had less tissue damaging under the GVL's guidance.

Compared with direct MacIntosh laryngoscope, the GVL had been reported that it can decrease the intubation time and increase the successful rate of first intubation in normal and difficult airways. However, the efficacy of the GVL in intubating the DLT was unclear and had never been evaluated. Therefore, the aim of this study was to compare the intubation conditions, safety, and patient comfort between using the GVL and the direct Macintosh laryngoscope in a specific population of patients needed DLT intubation. Main outcome measures were intubation success rates and the time needed to intubate the DLT with the two devices.

Read the detailed description

The study protocol was approved by the Institutional Research Board of the Memorial Hospitals of Kaohsiung Medical University and all patients included in the study gave written informed consent. Sixty patients with American Society of Anesthesiologists physical status I-III, ≧ 18 years of age, and needed double-lumen endotracheal tube (DLT) for thoracic surgery were enrolled in this study. Exclusion criteria were increased risk for regurgitation and pulmonary aspiration, history of gastroesophageal reflux, and pregnancy. Furthermore, when a tracheostomy or prolonged ventilation on ICU was planned, patients were also excluded. All tracheal intubations in the study were performed by two experienced (> 10 year) Board Certified anesthesiologists who each had experience of at least 300 tracheal intubations with each device before starting the study.

After the patient had entered the operating room, standard monitoring including ECG, invasive blood pressure measurement on the radial artery and pulse oximetry were established. Patients were randomly assigned to direct MacIntosh laryngoscope group (Group M, n = 30) or GVL group (Group G, n = 30) by opening a sealed envelope after they had entered the operating theatre. Anesthesia was induced with propofol 2-3 mg.kg-1, fentanyl 2μg.kg-1, and rocuronium 0.6mg.Kg-1. After achieving adequate muscle relaxation and anesthetic depth, DLT intubation was performed with direct laryngoscope or GVL. The bronchial and the tracheal cuff of the DLT were lubricated with SURGILUBE® sterile, surgical lubricant (E. FOUGERA \& CO. Melville, New York, A division of Nycomed US Inc.) thinly before intubation.

Measurements The demographic characteristics of both groups included age (years), gender (female/male), weight (kg), height (cm), body mass index (BMI), and ASA classification were recorded. The airway characteristics included the modified Mallampati classification, mouth opening (active and passive), and the thyromental distance were also recorded. Patients were measured of thyromental distance and incisor gap on maximal opening of the mouth and grading of The modified Mallampati classification in the operative room by another anesthesiologist not involved in the study. Passive mouth opening was measured after induction of anesthesia. After pre-oxygenation with oxygen 100%, patients received thiamylal 5 mg.kg-1 and fentanyl 2μg.kg-1 for anesthesia induction and facilitated DLT intubation with rocuronium 0.8 mg.kg-1 and propofol 1.0 mg.kg-1.

The total time to calculate DLT insertion (T3) was separated into T1 and T2, respectively, defined as started after jaw opening when the GVL or the direct laryngoscope passed the patient's lips and stopped when three complete waves of end-tidal CO2 showed on the monitor of capnography and measured by an independent observer. T1 time interval was calculated from the jaw opening, placement of GVL or standard Macintosh laryngoscope, to the view of glottis opening. T2 time interval was calculated from intubator holding DLT to three complete waves of end-tidal CO2 showed on the monitor of capnography. The procedures to position of DLT were declared in brief as following: the distal 10-12cm of the DLT was curved to approximately 90°; a conventional laryngoscope in group M and a Glidescope in group G to assist position DLT into trachea [4]; the tip of the DLT bronchial lumen was passed through the vocal cords and advanced into the glottis; to remove stylet of DLT; 180° counterclockwise rotation to facilitate the insertion of the bronchial cuff and tracheal lumen past the vocal cords; an additional 90° clockwise rotation to fit the tube into left main bronchus [5]. Grading of laryngo-pharyngeal tissues viewed by intubator according to the Cormack and Lehane classification (grades I-IV) that defined as grade I- complete glottis visible, grade II- anterior glottis not seen, grade III- epiglottis seen, but not glottis, and grade IV- epiglottis not seen [6]. The intubator determined the grades of laryngeal viewing either by direct laryngoscope or by Glidescope® with video monitor. The backwards upwards rightwards pressure (BURP) maneuver to optimize the glottis view was also recorded and the pressure grading was defined as none, light, and heavy.

After the blade of laryngoscope or GlideScope® was removed, we examined blood coating on its surface. The oral cavity, pharynx and larynx for signs of lacerations or bleeding provoked by the intubation was also examined by another otolaryngologist 5 minutes later, who was not aware of the chosen technique to complete intubation.

Hemodynamic parameters were recorded in the operating theatre after starting standard monitoring. Measurement of hemodynamic parameters included of time interval of baseline, intubation and post-intubation 1, 3 and 5 min, respectively. Anesthesia was maintained with sevoflurane. At the end of surgery, patients were trained to breathe spontaneously. The DLT was removed when spontaneous ventilation reached a tidal volume of 8 ml/kg and the patient could respond to simple verbal commands. The patients were interviewed by an independent investigator to determine whether they were suffering from a sore throat or dysphagia the next day of post-operation. We quantified the degree of soreness of the throat and dysphagia by using a visual analogue scale ranging from 0 to 10, with VAS 0 being rated as 'none', 1-3 as 'mild', 4-6 as moderate' and 7-10 as 'severe'.

Assuming a likely difference in mean times to intubate of 10 s with a SD of 10 s, an a priori power analysis revealed a group size of n = 27 was needed to detect a difference with a power of 0.8 at α-level of 0.05. Statistical analysis was performed using the Mann-Whitney U-test for non-parametric and univariate ANOVA for parametric data. Duncan's post-hoc test was performed where appropriate. Hemodynamic data were analyzed with ANOVA for repeated measures. Data are expressed as mean (SD) where applicable or actual numbers. SPSS 16.0.1 software (Apache Software Foundation, Forest Hill, MD, USA) was used for all statistical analyses.

Being tested
DLT intubation
Keywords
left-sided double lumen bronchial tube, GlideScope videolaryngoscope, direct laryngoscope

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • DLT intubationProcedure or surgery

    Also called Intubation with GlideScope

    Using a video-assisted laryngoscope to facilitate endotracheal tube intubation

Study groups in NCT01424605
Study groupRoleWhat they receive
DLT intubationExperimentalNot described
Receives: Procedure: DLT intubation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Main outcome measure is the successful rate of the first intubation compared with the two devices

    Measured: 12 month

Secondary outcomes (3)
  1. The outcome measure is the time needed to inert the DLT compared with the two devices

    Measured: 12 months

  2. The outcome measure were the hemodynamic parameters (such as mean blood pressure, and heart rate) compared with the two devices.

    Measured: 12 months

  3. The outcome measure is the incidence of complications (such as sorethroat, oral bleeding, and hypoxemia) compared with the two devices.

    Hypoxemia is defined as the SPO2 is below 90%.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Aug 2011 (estimated)
  2. Study startJan 2010
  3. Primary completionDec 2010
  4. Study completionDec 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01424605
Sponsor's protocol ID
KMUH-IRB-980393
Other IDs
KMUH-IRB-980393
Acronym
Glidescope
Status last verified
Aug 2011
First submitted
18 May 2011
Last updated
29 Aug 2011
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing DLT intubation in people with Anesthesia Intubation Complication, run by Kaohsiung Medical University Chung-Ho Memorial Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Aug 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Main outcome measure is the successful rate of the first intubation compared with the two devices (time frame: 12 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Aug 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in